Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Epigenetics
100%
Triple-negative Breast Cancer
100%
Combined Treatment
100%
Tumor-initiating Cells
100%
Entinostat
100%
Doxorubicin
71%
Retinoic Acid Receptor
42%
Tumor Regression
28%
Topoisomerase II
28%
All-trans Retinoic Acid
28%
Breast Cancer
14%
Breast Tumor
14%
Receptor Expression
14%
Cell Differentiation
14%
Cytotoxicity
14%
Epithelium
14%
Retinoids
14%
Induced Differentiation
14%
Transcriptional Repression
14%
Histone Deacetylase Inhibitor (HDACi)
14%
Cellular Differentiation
14%
Standard of Care
14%
Cancer Stem Cells
14%
Antitumor Agents
14%
Breast Cancer Xenograft
14%
Epigenetic Silencing
14%
Gene Expression Analysis
14%
Triple Therapy
14%
ETS Transcription Factors
14%
Effective Combination
14%
Chemotherapeutic Approaches
14%
ESE-1
14%
ELF3
14%
Patient-derived
14%
Metastatic Cancer Cells
14%
Doxorubicin Chemotherapy
14%
Differentiation Approach
14%
Medicine and Dentistry
Triple Negative Breast Cancer
100%
Cancer Stem Cell
100%
Entinostat
100%
Doxorubicin
85%
Retinoic Acid Receptor
42%
Cell Differentiation
28%
Tumor Regression
28%
DNA Topoisomerase (ATP Hydrolysing)
28%
Tretinoin
28%
Breast Cancer
14%
Transcription Factors
14%
Cytotoxicity
14%
Anticarcinogen
14%
Fibrinogen
14%
Breast Tumor
14%
Receptor Expression
14%
Retinoid
14%
Gene Expression Profiling
14%
Histone Deacetylase Inhibitor
14%
Tumor Xenograft
14%
Epithelium
14%
Biochemistry, Genetics and Molecular Biology
Cancer Stem Cell
100%
Doxorubicin
100%
Retinoic Acid Receptor
50%
Cellular Differentiation
33%
Tretinoin
33%
DNA Gyrase
33%
Transcription Factors
16%
Histone Deacetylase
16%
Cytotoxicity
16%
Retinoid
16%
Gene Expression Profiling
16%
Fibrinogen
16%
Nursing and Health Professions
Entinostat
100%
DNA Topoisomerase (ATP Hydrolysing)
28%